Scientific Project Leader in Proteomics
Evotec
Scientific Project Leader in Proteomics
Evotec
Drug discovery and preclinical development services
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.
Evotec provides drug discovery and preclinical development services for pharma, biotech, and academic partners across small molecules, biologics, and cell therapies, supported by molecular patient databases, multi-omics data, and iPSC-based disease modelling. It operates either as standalone services or integrated development programs and long-term partnerships, with Evotec Biologics handling biologics manufacturing and Cyprotex addressing in vitro and in silico ADME-toxicology; revenue comes from services, staffing contracts, technology licenses, milestones, and royalties. The company differentiates itself by offering end-to-end capabilities from discovery to manufacturing, backed by its data resources and specialized units. Its goal is to help partners move potential therapies from discovery to market faster through comprehensive, collaborative drug development and manufacturing.
Explore more opportunities at Evotec